Pharmaniaga charts strategic initiatives to exit PN17 status

PETALING JAYA: Pharmaniaga Bhd will focus on targeted initiatives aimed at streamlining business activities to exit its Practice Note 17 (PN17) status.

In a statement, executive committee chairman Ahmad Shahredzuan Mohd Shariff said the pharmaceutical company will optimise its overall business operations and costs, as well as finding synergies across all of its business units.